Rxo (RXO) Operating Leases (2021 - 2025)
Rxo's Operating Leases history spans 5 years, with the latest figure at $266.0 million for Q4 2025.
- For Q4 2025, Operating Leases fell 10.14% year-over-year to $266.0 million; the TTM value through Dec 2025 reached $266.0 million, down 10.14%, while the annual FY2025 figure was $266.0 million, 10.14% down from the prior year.
- Operating Leases reached $266.0 million in Q4 2025 per RXO's latest filing, up from $202.0 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $296.0 million in Q4 2024 to a low of $93.0 million in Q4 2021.
- Average Operating Leases over 5 years is $170.7 million, with a median of $150.0 million recorded in 2024.
- Peak YoY movement for Operating Leases: soared 108.8% in 2024, then fell 22.61% in 2025.
- A 5-year view of Operating Leases shows it stood at $93.0 million in 2021, then grew by 22.58% to $114.0 million in 2022, then rose by 28.07% to $146.0 million in 2023, then skyrocketed by 102.74% to $296.0 million in 2024, then dropped by 10.14% to $266.0 million in 2025.
- Per Business Quant, the three most recent readings for RXO's Operating Leases are $266.0 million (Q4 2025), $202.0 million (Q3 2025), and $201.0 million (Q2 2025).